Job Placement · Biotech and Life Sciences · Medical Affairs Director
Biotech medical affairs director placement on milestone billing, not contingency. The seat owns the scientific narrative a company presents to outside physicians and investigators, overseeing medical scientists priced by BLS at a 103,410 median, while the director's own code, natural sciences managers, runs a 167,220 median. BEG fills the seat in 23 to 35 days from 19,080.
See your placement estimate - no call required
See pricing before you talk to anyone. No demo gate, no obligation, and no co-employment.
TL;DR
A medical affairs director's own licensure turns on one line from BLS: treating patients in a trial requires it, interpreting or communicating the trial data to physicians, investigators and payers typically does not, and this seat lives on the communication side while still owning that external narrative, reporting to a VP. The natural sciences manager code prices the seat at a 167,220 median, above the 103,410 the medical scientists it represents externally earn. BEG prices the search from 19,080.
Why This Search Stalls
Companies want a medical affairs director with physician-level credibility in the exact therapeutic area, not just internal filing experience, and candidates who clear both the scientific and external-facing bar are priced at the natural sciences manager upper quartile of 221,540 to 316,850.
How BEG Fills This Seat
BEG scopes the seat to external medical credibility rather than internal filing work, sources for candidates the physician community already trusts, and clarifies the licensure question before the posting goes out.
| Step | What it requires | Where it stalls |
|---|---|---|
| Scope the external-facing mandate | A job description for the scientific and clinical narrative to physicians, investigators and payers, and oversight of the medical scientists who deliver it | Descriptions copy a regulatory director job description and add physician contact as an afterthought, missing the external-credibility bar entirely |
| Source for physician-level credibility | A candidate the external medical community already treats as credible in the exact therapeutic area | That credibility is built over years in the field and is concentrated in the same 221,540 to 316,850 upper range a regulatory director search competes against |
| Clarify the licensure question | Clarity on whether the seat itself treats patients, which requires a licence, or only interprets and communicates trial data, which typically does not | Postings that blur the two either overstate or understate what the role legally requires, and lose candidates on both sides of that line |
| Close against the equity question | A board decision on equity alongside base pay, matching what a director-level offer needs | The same equity deadlock that stalls a regulatory director search stalls this one, since both draw from the same natural sciences manager pay band |
Medical scientists, the team a medical affairs director represents externally, are projected to grow 13 percent through 2035 with about 10,500 openings a year, so BEG treats the director search and the team-building problem underneath it as connected, not separate.
Milestone Billing Against Contingency
The Tier IV fee, 19,080 to 22,896, is fixed to the search rather than a percentage of salary, so it does not move whether the director's own pay lands at the manufacturing median or the research and development one. Medical scientist pay is what actually swings by employer here, from 125,700 in research and development and 106,800 in pharmaceutical manufacturing down to 98,620 in hospitals and 74,970 at state universities, a spread that matters because it prices the team this director represents externally, not the director's own offer.
The Medical Affairs Math
Licensure, not filing history, is what actually separates this seat's external mandate from a regulatory director's internal one, and BEG's fee reflects the director's own pay code rather than the licensed-or-unlicensed team beneath it. Tier IV runs 19,080 to 22,896, 57 to 68 percent of the 33,444 a 20 percent contingency recruiter would bill against the 167,220 natural sciences manager median (BLS), and 52 to 62 percent against the 185,110 manufacturing median. Measured against the medical scientists this director actually represents externally, who earn a separate, lower 103,410 median themselves (BLS), the fee looks smaller still, proof it tracks the director's own code and never an inflated one. BEG is cheaper than contingency at every wage point cited for this role.
Contingency, BEG, or Temp
A contingency recruiter prices this search like any six-figure hire; BEG prices it like what it actually is, external-facing credibility measured against the director's own code, at 32 to 55 percent below a 20 percent contingency fee.
| Model | Who employs | How you pay | Right when |
|---|---|---|---|
| Contingency recruiter | You, direct | A recruiter’s percentage of first-year salary, typically 20 to 25 percent, billed at start | A director search where a fee tied to a six-figure base is acceptable |
| BEG milestone placement | You, direct hire | A Tier IV fee fixed at 19,080 to 22,896, billed in stages as the search progresses | A physician-facing director hire where BEG runs 32 to 55 percent below a 20 percent contingency fee depending on benchmark |
| Staffing or temp agency | The agency, not you | An hourly bill rate plus markup, running for as long as the assignment lasts | Interim medical affairs coverage during a leave or transition, not a permanent director hire |
This tier prices external, physician-facing credibility, not internal filing work, which is why it sits alongside a regulatory director's tier rather than a specialist's. See every tier and role BEG places across the vertical on the hub.
FAQ
The director owns the scientific and clinical narrative a company presents to outside physicians, investigators and payers, and oversees the medical scientists and liaisons who carry that narrative into the field, reporting to a VP. A director of clinical/regulatory, who owns submissions and agency interactions internally, does not carry this external mandate.
Companies want a director with physician-level credibility in their exact therapeutic area, not just internal filing experience. Candidates who clear both the scientific and external-facing bar are priced at the natural sciences manager upper quartile of 221,540 to 316,850, the same range a pure regulatory director search competes against.
This role shares BEG’s Tier IV milestone fee with a director of clinical/regulatory, 19,080 to 22,896, because both are priced through the same natural sciences manager code. The bill stages against the search, not a percentage of salary.
BEG holds the same 23 to 35 day timeline and 86 percent fill rate it runs for a director of clinical/regulatory search, since both draw candidates from the same natural sciences manager pay band, though this search screens for physician-facing credibility rather than filing history.
It depends on the work. BLS says medical scientists who treat patients in clinical trials must be licensed as physicians or other practitioners, while those who conduct research or communicate trial data without treating patients typically need no licence.
Medical scientists, the population a medical affairs director represents to the outside medical community, earn a 103,410 median and are projected to grow 13 percent through 2035 with about 10,500 openings a year. Metro pay for that team runs from a 160,180 median in San Francisco and 129,500 in Boston, the largest single metro in the file at 16,060 jobs, down to 103,360 in New York and 79,470 in Dallas.
FDA’s September 2025 E6(R3) Good Clinical Practice guidance clarifies sponsor and investigator responsibilities and advances risk-based quality management, the framework medical affairs communications about trial data have to stay consistent with.
Both are priced at BEG’s Tier IV and draw on the same natural sciences manager pay code. A director of clinical/regulatory owns internal submissions and agency interactions; a medical affairs director owns the external narrative to physicians, investigators and payers.
Compare this seat with the director of clinical / regulatory role it shares a pay tier with, or the VP of R&D / clinical seat above it. Every biotech role BEG places is on the Biotech and Life Sciences hub.
More Biotech and Life Sciences placement
Ready?
Answer a few questions, get your placement estimate in about 90 seconds. No call required, no commitment.
See your placement estimate - no call required
